Publications

2
Oct

Genoskin & LEO Pharma publish data on inflammation model InflammaSkin® in Experimental Dermatology

Genoskin & LEO Pharma publish data on inflammation model InflammaSkin® in Experimental Dermatology Genoskin’s amazing team of experts is always developing new and improved ex vivo human skin assays. This time, we partnered with LEO Pharma to develop a brand new inflammation model: InflammaSkin®. Genoskin is proud to announce that its unique skin assay is now fully described in Experimental
Read more
21
Feb

New published data generated using Genoskin assays

New published data generated with Genoskin human skin assays Genoskin assays are designed for fast and reliable studies with reproducible results. As we aim to empower research teams with the best technology to generate better human data, we are proud to discover new published data involving our skin assays.  The potential to evaluate nanoparticles toxicity In NanoImpact, a research team
Read more
10
Jan

Incospharm publishes results using NativeSkin®

Incospharm publishes results using NativeSkin® Korean company Incospharm publishes data generated using our hi-tech human skin assay, NativeSkin®, in the International Journal of Molecular Sciences. Incospharm developed an innovative complex of peptides meant to stimulate the skin basement membrane proteins expression for anti-aging effects. The ex vivo evaluation using NativeSkin® confirmed that the topical application of this peptide complex significantly
Read more
22
Feb

Ex vivo human skin models for cosmetic testing

Standardized ex vivo skin models for cosmetic testing Cosmetic testing is playing an increasingly important role in today’s cosmetic industry. The first cosmetic tests took place in 1933, after an eyelash darkening treatment blinded several women. In 1938, the U. S. Food and Drug Administration passed the Federal Food, Drug & Cosmetic (FD&C) Act to define stricter regulations for cosmetic products
Read more
21
Sep

Study on indoor air pollution uses NativeSkin® model

New study on effects of indoor air pollution on human skin uses NativeSkin® models Indoor air pollution may alter human skin. A study that was recently published in Scientific Reports  shows that volatile organic compounds target the cellular mechanism that eliminates damaged proteins. The study uses Genoskin's NativeSkin® model to study the effects of indoor air pollution on human skin and
Read more
15
May

Oriflame study uses NativeSkin® human skin explant model

NativeSkin®, a novel skin explant model for skin delivery assessment The Genoskin team is proud to announce that Oriflame Cosmetics published an article in the March 2015 edition of Cosmetics & Toiletries under the title “A Novel Skin Explant Model For Skin Delivery Assessment”. The work presented in this article was conducted by Oriflame’s cosmetics experts in their facility in Stockholm. Genoskin has

Read more